Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Reexamination Certificate
2000-10-11
2002-11-26
Park, Hankyel T. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
C435S005000
Reexamination Certificate
active
06485929
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to a method of inhibiting CD95-independent apoptosis, in particular in the case of AIDS. The invention also relates to a system for identifying substances which can be used for inhibiting CD95-independent apoptosis.
BACKGROUND OF THE INVENTION
AIDS is characterized by a depletion of CD4
+
T cells and a dysfunction of the immune system. Previous data refer to the fact that a depletion occurs because the CD95 receptor is activated by the CD95 ligand present in increased amount in the presence of the glycoprotein gp120 of HIV, so that apoptosis, i.e. programmed cell death, is induced in CD4
+
T cells. This apoptosis is referred to as CD95-mediated apoptosis.
Experiments have been made to prevent the depletion of CD4
+
T cells in the case of AIDS. For this purpose, methods were carried out with substances which block the bonding of the CD95 ligand to the CD95 receptor. However, these methods did not fully prevent the depletion of CD4
+
T cells.
Therefore, it is the object of the present invention to provide a method by which the depletion of CD4
+
T cells in the case of AIDS can be investigated and optionally be prevented.
According to the invention this is achieved by the subject matters defined in the claims.
SUMMARY OF THE INVENTION
The subject matter of the present invention relates to a method of inhibiting CD95-independent apoptosis, the method comprising the steps of:
(a) blocking the bonding of HIV-1 gp120 to receptors CD4 and/or CXCR4 and blocking a factor competing for this bonding, respectively, and/or
(b) inhibiting the signal path induced by the bonding of (a).
REFERENCES:
Radrizzani, et al., “IL-12 Inhibits Apoptosis Induced In A Human Th1 Clone By gp120/CD4 Cross-Linking and CD3/TCR Activation or By IL-2 Deprivation”,Cell. Immunol., 161:14-21 (Mar., 1995).
Corbeil, J. and Reichman, D.D., “Productive Infection and Subsequent Interaction of CD4+T Cells”,Journal of General Virology, 76:681-690, (1995).
Berndt, C. et al., “CXCR4 and CD4 Mediate A Rapid CD95-Independent Cell Death In CD4+T Cells”,Proceedings of the National Academy of Sciences of USA, 95:12556-12561, (Oct., 1998).
Berndt Christina
Krammer Peter
Deutsches Krebsforschungzentrum Stiftung des offentlichen Rechts
Halluin Albert P.
Howrey Simon Arnold & White , LLP
Kung Viola T.
Park Hankyel T.
LandOfFree
Method for inhibiting CD95-independent apoptosis in AIDS does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting CD95-independent apoptosis in AIDS, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting CD95-independent apoptosis in AIDS will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2978860